Reviewnpj biodiversity2026
Microbial diversity as the next frontier of payments for ecosystem services in nature-positive finance.
Review in npj biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Payments for Ecosystem Services (PES) have matured across forests (carbon), watersheds (water quality and quantity), agricultural landscapes (biodiversity), and urban stormwater management. Most biodiversity assessments emphasize insects, fish, and birds. By contrast, schemes that directly measure and reward the microbial diversity, the foundations of ecosystem services in soils, aquatic systems, and urban green spaces, remain scarce. Meanwhile, the Kunming-Montreal Global Biodiversity Framework calls for mobilizing at least USD 200 billion per year by 2030, and the Global Biodiversity Framework Fund has launched; but current flows into PES are limited, and PES explicitly targeting microbes is largely uncharted. This Perspective argues that microbially focused PES is rare and, even when they exist, they tend to be biased toward specific pathogens or pollution indicators. However, measurement, reporting, and verification of various microorganisms are operationally feasible and methods to strengthen source attribution and contribution estimation are now mature; and channeling a share of Nature-Positive finance to microbial ecosystem assessments could jointly advance drinking-water safety, soil health, agricultural resilience, and urban public health. We discuss the importance of microbial-PES in conserving and enhancing ecosystem services.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.